Mechanisms behind Interindividual Variations in Diseases

Summary

I discovered a fundamental difference between Kentʼs and Hahnemannʼs concepts of disease, which has undervalued the importance of disease pathophysiology in homeopathic therapeutics. I argue that biological mechanisms operating behind interindividual variations in disease can explain those symptoms, which are peculiar to a patient. My study shows that interindividual variations in diseases arise due to multiple factors including interindividual variability in vascular supply, influence of pharmacological agents, age factor and interindividual variations in host immunogenetic factors. These factors contribute to individual specific pathophysiologic mechanisms, which give rise to individual specific clinical features. Knowledge of these mechanisms can overcome limitations associated with clinical features.

Key words

Kentʼs theory - MHC (Major Histocompatibility Complex) - Peculiar symptoms - Interindividual variations

• References

• 1 Roberts HA. The Chief Complaint and the Auxiliary Symptoms in Their Relation to the Case. The Principles and Art of Cure by Homoeopathy (reprint edition). New Delhi: B. Jain Publishers (P) Ltd.; 1993: 101
• 2 Kent JT. The Examination of the Patient. Lectures on Homoeopathic Philosophy (reprint edition). New Delhi: B. Jain Publishers (P) Ltd.; 1991: 162
• 3 Green JM. How to prescribe homoeopathic drugs. The Homoeopathic Recorder 1904; XLIII: 396-401
• 4 Walach H, Hausler W, Lowes T et al. Classical homoeopathic treatment of chronic headaches. Cephalalgia 1997; 17: 119-126
• 5 Peter F. An experimental double-blind clinical trial method in homoeopathy: use of a limited range of remedies to treat fibrositis. Br Hom J 1986; 75: 142-147
• 6 Andrade LEC, Ferraz MB, Atra E et al. A randomized controlled trial to evaluate the effectiveness of homoeopathy in rheumatoid arthritis. Scand J Rheumatology 1991; 20: 204-208
• 7 Gibson RG, Gibson SLM, MacNeill AD et al. Homoeopathic therapy in rheumatoid arthritis: evaluation of double-blind clinical trial. Br J Clin Pharmac 1980; 9: 453-459
• 8 Hahnemann S. Organon of Medicine (6th ed.). New Delhi: B. Jain Publishers (P) Ltd.; 1993. 160. 169-171
• 9 Hayreh SS. The optic nerve head circulation in health and disease. Exp Eye Res 1995; 61: 259-272
• 10 Zwan A, Hillen B. Review of the variability of the territories of the major cerebral arteries. Stroke 1991; 22: 1078-1084
• 11 Smith WS, Hauser SL, Easton JD. Cerebrovascular Diseases. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrisonʼs Principles of Internal Medicine (15th ed.), Vol. II. New Delhi: McGraw-Hill; 2001: 2372
• 12 Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs. N Engl J Med 1999; 340: 1888
• 13 Cappell MS, Schein JR. Diagnosis and treatment of nonsteroidal anti-inflammatory drug-associated upper gastrointestinal toxicity. Gastroenterol Clin North Am 2000; 29: 97-124
• 14 Miller D, Yoshikawa T, Castle SC et al. Effect of age on fever response to recombinant tumor necrosis factor alpha in murine models. J Gerontol 1991; 46: M176-M179
• 15 Gleckman R, Hibert D. Afebrile bacteremia a phenomenon in geriatric patients. JAMA 1982; 248: 1478-1481
• 16 Finkelstein MS, Petkum WM, Freedman ML et al. Pneumococcal bacteremia in adults: age-dependent differences in presentation and in outcome. J Am Geriatr Soc 1983; 31: 19-27
• 17 Tiwari J, Terasaki P. The HLA Complex. HLA and Disease Associations, Overview. New York: Springer; 1985: 8-13 43–48
• 18 Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. CMR 2009; 22: 370-385
• 19 Danis VA, Millington M, Hyland VJ et al. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 1995; 99: 303-310
• 20 Molvig J, Baek J, Christensen P et al. Endotoxin-stimulated human monocyte secretion of interleukin 1, tumor necrosis factor alpha, and prostaglandin E2 shows stable interindividual differences. Scand J Immunol 1988; 27: 705-716
• 21 Saurez A, Castro P, Alonso R et al. Interindividual variations in constitutive interleukin-10 messenger RNA and protein levels and their association with genetic polymorphisms. Transplantation 2003; 75: 711-717
• 22 Kotb M, Norrby-Teglund A, McGeer A et al. Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience. Scand J Infect Dis 2003; 35: 665-669
• 23 Kotb M, Norrby-Teglund A, McGeer A et al. An immunogenetic and molecular basis for differences in outcomes of invasive group a streptococcal infections. Nature Medicine 2002; 8: 1398-1404
• 24 McGuire W, Hill AVS, Allsopp CEM et al. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508-511
• 25 Grau GE, Taylor TE, Med MT et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989; 320: 1586-1591
• 26 Cabrera M, Shaw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182: 1259-1264
• 27 Conna UV, Fazou C, Cameron B et al. Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. Psychol Med 2004; 34: 1289-1297
• 28 Konsman JP, Parnet P, Dantzer R. Cytokine-induced sickness behaviour: mechanism and implications. Trends Neurosci 2002; 25: 154-159
• 29 Cleeland HS, Bennett GJ, Dantzer R et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer 2003; 97: 2919-2925
• 30 Miaskowski C, Dodd M, Lee K et al. Preliminary evidence of an association between a functional IL6 polymorphism and fatigue and sleep disturbance in oncology patients and their family caregivers. J Pain Symptom Manage 2010; 40: 531-544
• 31 Kiecolt-Glaser JK, Preacher KJ, MacCallum RC et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. PNAS 2003; 100: 9090-9095
• 32 Maes M, Lin AH, Delmeire L et al. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events. Biol Psychiatry 1999; 45: 833-839
• 33 Lutgendorf SK, Garand L, Buckwalter KC et al. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol 1999; 54A: M434-M439